Tony Reid

Company: EpicentRx

Job title: Chief Executive & Scientific Officer

Seminars:

Discussion Panel: Debating the Promise of Combinational Strategies with TGF-β 1:00 pm

Read more

day: Day Two

Exploring the Clinical Stage TGF-β Fusion Protein Expressing Oncolytic Virus, AdAPT-001 9:00 am

Highlighting the safety and tolerability of TGF-β targeting OV, AdAPT-001 Using correlative studies for measuring expression in the clinic Discussing neutralizing TGF-β for improving checkpoint inhibitorsRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.